Markets:

Overview

News

Currencies

International

Treasuries

Johnson & Johnson (NY:JNJ)

280.41 UNCHANGED

Delayed Quote Updated: 7:00 PM EST, Nov 11, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Johnson & Johnson

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

These 5 Dividend Aristocrats® Have Raised Payouts for Decades ↗

November 11, 2026

Investors worried about market turmoil may want to look at reliable dividend stocks, and these five stand out.

Via The Motley Fool

Topics Economy

Johnson & Johnson vs. Eli Lilly: Which Healthcare Giant's Stock Is a Better Buy for 2027? ↗

November 11, 2026

Eli Lilly's sales jumped 44.7% last year, while Johnson & Johnson's steadier profile raises a different question for cautious portfolios.

Via The Motley Fool

Johnson & Johnson Sees a Path to Double-Digit Growth by 2030. Is the Dividend King a Buy? ↗

November 11, 2026

The business has undergone major changes in recent years, and these might pay off over the medium term.

Via The Motley Fool

Topics Intellectual Property

Johnson & Johnson (NYSE:JNJ): A Dividend Quality Case Study for Income Investors ↗

November 09, 2026

Via Chartmill

Dow Jones Top Gainers on Oct. 20, 2026: MMM, UNH, MRK Lead Session ↗

October 20, 2026

Via Chartmill

Topics Stocks

The AI Debt Bill Is Coming Due, But Biotech Has Revenue to Show for the Boom ↗

November 11, 2026

AI infrastructure is being funded with debt and stock sales while biotech companies applying AI are booking revenue, led by Tempus AI, Recursion and iShares Biotechnology

Via MarketBeat

Topics Artificial Intelligence Bankruptcy

Stocks Fell After the Midterms. History Says the Next 12 Months Could Be Very Different ↗

November 10, 2026

Keep focusing on the long term.

Via The Motley Fool

Topics Artificial Intelligence ETFs Economy

Stock Market Sell-Off: Meet the Unstoppable Vanguard ETF Obliterating the S&P 500 in 2026 ↗

November 10, 2026

Value stocks are crushing growth stocks as investors sour on the artificial intelligence trade.

Via The Motley Fool

Topics Artificial Intelligence ETFs Economy

The Buffett Indicator Is Flashing Red. These 3 Dividend Stocks Could Be Safe Havens. ↗

November 10, 2026

The stock market is looking overvalued, according to this indicator.

Via The Motley Fool

Topics Artificial Intelligence Economy

4 Stocks I'm Not Selling Even If the Fed Keeps Raising Rates ↗

November 06, 2026

Some companies will perform pretty well regardless of whether or not interest rates rise.

Via The Motley Fool

Topics Economy

2 Growth Stocks to Buy in November Without Any Hesitation ↗

November 05, 2026

They have both outperformed the broader equity market over the long run.

Via The Motley Fool

Worried About an AI Bubble? This ETF Could Be the Smartest Buy Right Now ↗

November 03, 2026

This ETF offers a smart middle ground for investors anxious about the AI trade but who don't want to sit on the sidelines.

Via The Motley Fool

Topics Artificial Intelligence ETFs

The Best Dividend Stocks to Buy With $5,000 in November ↗

November 02, 2026

AbbVie, J&J, and Medtronic remain reliable dividend plays in a rough market.

Via The Motley Fool

Topics Artificial Intelligence Economy

Intuitive Surgical Stock Just Fell Despite a 22% Revenue Jump. Here's What Investors Are Missing. ↗

November 01, 2026

Selling surgical robots is not the largest source of Intuitive Surgical's revenue.

Via The Motley Fool

Medtronic Just Retired 55 Million Shares Without Spending Cash. Is the Stock a Buy? ↗

November 01, 2026

Medtronic grew revenue by 14% in the first quarter of its fiscal 2027.

Via The Motley Fool

If a Bear Market Is Coming, History Says These Stocks Could Be the Smartest to Own ↗

October 31, 2026

Consumers don't stop buying vital products during bear markets, which is why healthcare and consumer staples stocks are smart investments.

Via The Motley Fool

Johnson & Johnson Just Took $7 Billion in Charges and Still Raised Its Outlook. Here's What That Tells Investors. ↗

October 30, 2026

Johnson & Johnson's third-quarter 2026 earnings look terrible, until you dig into the story a little bit more.

Via The Motley Fool

Topics Lawsuit

Warren Buffett Says Most Investors Should Buy the S&P 500. Here's How Much You Can Actually Earn With This ETF. ↗

October 30, 2026

Instead of trying to pick stocks like Warren Buffett, follow his advice and buy this S&P 500 ETF.

Via The Motley Fool

Topics ETFs Economy Stocks

3 Unstoppable S&P 500 Stocks to Buy Before October Ends ↗

October 29, 2026

With just two days to go, these Dividend Kings with attractive yields could be just what you are looking for in October.

Via The Motley Fool

Topics Economy Stocks

5 Beaten-Down Growth Stocks Trading Like Value Plays as Cash Chases Mega-Caps ↗

October 26, 2026

Teradyne, Grail, Kratos Defense, FormFactor and Fabrinet have pulled back despite strong growth, setting up potential entry points in robotics, quantum and AI.

Via MarketBeat

Topics Artificial Intelligence

Amgen vs. Johnson & Johnson: Which Healthcare Giant Has the Better Stock to Buy? ↗

October 24, 2026

Amgen trades at a lower valuation multiple, but Johnson & Johnson's fortress balance sheet and stronger free cash flow tell a different story about financial resilience.

Via The Motley Fool

Dow Jones Top Movers Today: PG and JNJ Lead Gainers, CAT and AMZN Lead Losers ↗

October 22, 2026

Via Chartmill

Topics Stocks

Dow Jones Top Movers: Gainers and Losers on October 22, 2026 ↗

October 22, 2026

Via Chartmill

Topics Stocks

Intuitive Surgical Stock: Margin Hit Masks Strong Q3 Growth Story ↗

October 22, 2026

Intuitive Surgical posted Q3 margin impairments from a legal settlement and pricing changes, but revenue grew 21.5%, guidance firmed, and analysts and institutions remain bullish on ISRG.

Via MarketBeat

Topics Lawsuit

Not Lilly. Not Johnson & Johnson. This Stock Will Be the Biggest Healthcare Winner of 2026 ↗

October 21, 2026

The market has rewarded this biotech for its breakthroughs.

Via The Motley Fool

2 Dividend Stocks Crushing the Market in 2026 (and Which Ones Can Keep Going) ↗

October 20, 2026

These drugmakers are facing some near-term challenges, but is that enough to stop their recent momentum?

Via The Motley Fool

What a Mixed Midterm Result Could Mean for These 2 Health Care ETFs ↗

October 19, 2026

Polls suggest a divided government after the midterms, a scenario that historically benefits healthcare stocks. Here's how the XLV and IHF ETFs compare for investors eyeing the sector.

Via MarketBeat

Topics ETFs

Should You Invest in This Dividend King on the Dip? ↗

October 17, 2026

Looking beyond near-term headwinds paints a fairly bright picture of Johnson & Johnson’s outlook.

Via The Motley Fool

When the Stock Market Gets Dangerous, These 6 Investments Have a History of Holding Up ↗

October 17, 2026

These companies generate resilient revenues, which help make their stocks less volatile during market downturns.

Via The Motley Fool

Topics Economy

MarketBeat Week in Review – 10/12 - 10/16 ↗

October 17, 2026

Tech stocks fell on inflation fears and AI infrastructure concerns while the Dow rose, as MarketBeat analysts review earnings outlooks, sector rotation, and stock picks from the week's top stories.

Via MarketBeat

Topics Artificial Intelligence Economy Stocks

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Johnson & Johnson (NY:JNJ)

Headline News about Johnson & Johnson

Starting at /week.